No Data
Market Chatter: JD.com's Healthcare Arm Shuttering Family Doctor Initiative
Chinese e-commerce giant JD.com (HKG:9618) closed its healthcare arm JD Health International's (HKG:6618) family doctor division after failing to turn a profit, Yicai Global reported Tuesday, citing a
Despite slow growth, Ali Health is gradually becoming “healthy”
Jinwu Financial News | On May 27, Alibaba Health (00241.HK) announced its annual results for the 2024 fiscal year ending March 31, 2024. During the reporting period, it achieved revenue of 27.027 billion yuan, a slight increase of 1.0% year on year, and realized net profit of 883 million yuan, an increase of 64.6% year on year, with a significant increase in profit against the backdrop of flat revenue growth. The number of members of over 77 million and a MAU of up to 300 million have made Ali Health's current earnings report very popular. Driven by the results, Alibaba Health Hong Kong stock surged 10% on the 28th.
Trending Industry Today: ALI HEALTH Leads Gains In Digital Health Stocks
May 28th - The industry of $Digital Health(LIST1251.HK)$ is trending higher today with 4 constituents up and ALI HEALTH leading Gains.$ALI HEALTH(00241.HK)$ rises 11.72% to HK$3.43 with a turnover of
SciNet shares, Pusheng Ali Health (00241), rose 12.05%, and UBS's views on Chinese stocks turned positive, favoring Technet stocks, etc.
Jinwu Financial News | SciNet stocks rose 12.05%, JD Health (06618) rose 5.15%, Shell (02423) rose 2.5%, Baidu (09888) rose 1.22%, followed by Tencent (00700), Bilili (09626), and Alibaba (09988).
JD Health (06618) issues 350,000 shares under the initial public offering after-sale share incentive plan
JD Health (06618) issued an announcement on May 17, 2024, as adopted on November 2, 2020...
[Hong Kong Stock Connect] JD Health (06618) turned 2.58%. Non-IFRS operating profit fell 34.8% in the first quarter
Jinwu Financial News | JD Health (06618) fluctuated and declined. It once rose more than 2.4% in early trading and fell as low as 3.07% in the afternoon. As of press release, it was reported at HK$30.15, still down 2.58%, with a turnover of HK$236 million. JD Health announced that for the three months ended March 31, 2024, non-IFRS operating profit was 754 million yuan (RMB, same below), a year-on-year decrease of 34.8%; operating profit of 487 million yuan, a decrease of 38.7%; and revenue of 13.267 billion yuan, a decrease of 4.9%.